首页 > 最新文献

Diseases (Basel, Switzerland)最新文献

英文 中文
Apixaban-Induced Esophagitis Dissecans Superficialis-Case Report and Literature Review. 阿哌沙班诱发的浅表性食管闭锁炎--病例报告和文献综述。
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-21 DOI: 10.3390/diseases12100263
Alexandru Ionut Coseru, Irina Ciortescu, Roxana Nemteanu, Oana-Bogdana Barboi, Diana-Elena Floria, Radu-Alexandru Vulpoi, Diana Georgiana Strungariu, Sorina Iuliana Ilie, Vadim Rosca, Vasile-Liviu Drug, Alina Plesa

Novel direct oral anticoagulants (DOACs) are prescribed worldwide in the treatment of non-valvular atrial fibrillation. Adverse reactions have been reported following the use of DOACs. One notable trend in the literature is the growing number of reported cases of esophagitis dissecans superficialis (EDS) generated by DOAC use. We hereby report the case of a 73-year-old woman who presented to the hospital with asthenia, dysphagia, and melena two days prior to admission. The patient had taken apixaban due to non-valvular paroxysmal atrial fibrillation for a few weeks. The biological panel showed moderate anemia with a hemoglobin level of 7.7 g/dL Apixaban-induced EDS was diagnosed by the characteristic endoscopic findings. The patient received treatment with a proton pump inhibitor (pantoprazole) in a double dose. Also, an iron treatment was recommended for a period of six months. The follow-up endoscopy at one month confirmed the healing of the esophageal lesions. The case was discussed with the cardiologist. The first anticoagulant treatment proposed after discharge was a vitamin K antagonist (acenocumarol) but the patient refused this medication and thus it was decided to initiate rivaroxaban. Although DOACs have demonstrated their efficacy in the prevention and treatment of stroke and thromboembolism among the aging demographic, cases of DOAC-induced EDS will continue to pose numerous challenges for physicians worldwide.

新型直接口服抗凝剂(DOACs)是全球治疗非瓣膜性心房颤动的处方药。使用 DOAC 后出现不良反应的报道时有发生。文献中一个值得注意的趋势是,越来越多的病例报告因使用 DOAC 而引发浅表性食管间质炎(EDS)。我们在此报告一例 73 岁女性患者的病例,她在入院前两天因气喘、吞咽困难和腹泻入院。患者因非瓣膜性阵发性心房颤动服用阿哌沙班数周。生物检查结果显示中度贫血,血红蛋白水平为 7.7 g/dL,阿哌沙班诱发的 EDS 是通过特征性内镜检查结果确诊的。患者接受了双倍剂量的质子泵抑制剂(泮托拉唑)治疗。此外,还建议患者接受为期六个月的铁剂治疗。一个月后的随访内镜检查证实食道病变已经愈合。该病例与心脏病专家进行了讨论。出院后建议的第一种抗凝治疗药物是维生素 K 拮抗剂(阿昔洛尔),但患者拒绝接受这种药物,因此决定使用利伐沙班。尽管 DOAC 在预防和治疗老年人群的中风和血栓栓塞方面已显示出其疗效,但 DOAC 引起的 EDS 病例仍将给全球医生带来诸多挑战。
{"title":"Apixaban-Induced Esophagitis Dissecans Superficialis-Case Report and Literature Review.","authors":"Alexandru Ionut Coseru, Irina Ciortescu, Roxana Nemteanu, Oana-Bogdana Barboi, Diana-Elena Floria, Radu-Alexandru Vulpoi, Diana Georgiana Strungariu, Sorina Iuliana Ilie, Vadim Rosca, Vasile-Liviu Drug, Alina Plesa","doi":"10.3390/diseases12100263","DOIUrl":"https://doi.org/10.3390/diseases12100263","url":null,"abstract":"<p><p>Novel direct oral anticoagulants (DOACs) are prescribed worldwide in the treatment of non-valvular atrial fibrillation. Adverse reactions have been reported following the use of DOACs. One notable trend in the literature is the growing number of reported cases of esophagitis dissecans superficialis (EDS) generated by DOAC use. We hereby report the case of a 73-year-old woman who presented to the hospital with asthenia, dysphagia, and melena two days prior to admission. The patient had taken apixaban due to non-valvular paroxysmal atrial fibrillation for a few weeks. The biological panel showed moderate anemia with a hemoglobin level of 7.7 g/dL Apixaban-induced EDS was diagnosed by the characteristic endoscopic findings. The patient received treatment with a proton pump inhibitor (pantoprazole) in a double dose. Also, an iron treatment was recommended for a period of six months. The follow-up endoscopy at one month confirmed the healing of the esophageal lesions. The case was discussed with the cardiologist. The first anticoagulant treatment proposed after discharge was a vitamin K antagonist (acenocumarol) but the patient refused this medication and thus it was decided to initiate rivaroxaban. Although DOACs have demonstrated their efficacy in the prevention and treatment of stroke and thromboembolism among the aging demographic, cases of DOAC-induced EDS will continue to pose numerous challenges for physicians worldwide.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of Hepatocellular Carcinoma by Sex in Mexico: A Multi-Institutional Collaboration. 墨西哥肝细胞癌的性别特征:多机构合作
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-21 DOI: 10.3390/diseases12100262
Javier Melchor-Ruan, Luis Santiago-Ruiz, Blanca Olivia Murillo-Ortiz, Samuel Rivera-Rivera, Yelda A Leal-Herrera, David Suárez-García, José María Remes-Troche, Peter Grube, Gustavo Martínez-Mier, Erika Ruiz-García, Alan Ramos-Mayo, José Antonio Velarde-Ruiz-Velasco, Ricardo Gamboa-Gutierrez, Karla Gabriela Ordoñez-Escalante, Laura Esthela Cisneros-Garza, Pilar Leal-Leyte, Jesús Sepúlveda-Delgado, María Saraí González-Huezo, Ricardo Arvizu-Castillo, Jorge Urías-Rocha, Celia Beatriz Flores-de-la-Torre, Leonardo Manuel Carrillo-Mendoza, Juan Manuel Gámez-Del-Castillo, Martín Lajous, Adriana Monge, Daniel Zamora-Valdés

Liver cancer is the fourth leading cause of cancer-related death worldwide. In Mexico, there is a high burden of liver cancer mortality in rural states, affecting both women and men equally. Thus, we aimed to describe the demographic and clinical characteristics of hepatocellular cancer (HCC) by sex in Mexico. Demographic and clinical information was extracted retrospectively from the medical records of patients with HCC initially treated (2015-2022) at institutions participating in a national survey across the country. The male-to-female ratio was calculated at the national and regional levels, and the results were stratified by sex. Among 697 HCC patients, the age at diagnosis was 65.4 ± 11.9 years and 20% were diagnosed at ≥75 years. The male-to-female ratio was 1.4:1, ranging from 1:1 in the northwestern and southwestern regions, to 2.1:1 in the western region. The proportion of cirrhosis was similar between the sexes; however, the etiology of cirrhosis differed: cryptogenic cirrhosis was higher in women and alcohol consumption was higher in men. Men had a higher proportion of advanced HCC, poor/undifferentiated tumors, and ≥4 nodules than women. HCC in the Mexican population affects both men and women at a 1.4:1 male-to-female ratio. This unique proportion by sex could be explained by the differences in the prevalence of risk factors across our heterogeneous country.

肝癌是全球第四大癌症致死病因。在墨西哥,农村地区的肝癌死亡率很高,女性和男性同样受到影响。因此,我们旨在按性别描述墨西哥肝细胞癌(HCC)的人口统计学和临床特征。我们从参与全国调查的机构中初步治疗的 HCC 患者的病历(2015-2022 年)中回顾性地提取了人口统计学和临床信息。计算了全国和地区层面的男女比例,并按性别对结果进行了分层。在697名HCC患者中,确诊年龄为(65.4±11.9)岁,20%的患者确诊年龄≥75岁。男女比例为 1.4:1,西北地区和西南地区为 1:1,西部地区为 2.1:1。男女肝硬化的比例相似,但肝硬化的病因不同:女性中隐源性肝硬化的比例较高,而男性中饮酒的比例较高。与女性相比,男性患晚期 HCC、贫/未分化肿瘤和结节≥4 个的比例更高。在墨西哥人群中,男性和女性的 HCC 患病率为 1.4:1。这种独特的性别比例可以用我们这个异质国家的风险因素流行率差异来解释。
{"title":"Characteristics of Hepatocellular Carcinoma by Sex in Mexico: A Multi-Institutional Collaboration.","authors":"Javier Melchor-Ruan, Luis Santiago-Ruiz, Blanca Olivia Murillo-Ortiz, Samuel Rivera-Rivera, Yelda A Leal-Herrera, David Suárez-García, José María Remes-Troche, Peter Grube, Gustavo Martínez-Mier, Erika Ruiz-García, Alan Ramos-Mayo, José Antonio Velarde-Ruiz-Velasco, Ricardo Gamboa-Gutierrez, Karla Gabriela Ordoñez-Escalante, Laura Esthela Cisneros-Garza, Pilar Leal-Leyte, Jesús Sepúlveda-Delgado, María Saraí González-Huezo, Ricardo Arvizu-Castillo, Jorge Urías-Rocha, Celia Beatriz Flores-de-la-Torre, Leonardo Manuel Carrillo-Mendoza, Juan Manuel Gámez-Del-Castillo, Martín Lajous, Adriana Monge, Daniel Zamora-Valdés","doi":"10.3390/diseases12100262","DOIUrl":"https://doi.org/10.3390/diseases12100262","url":null,"abstract":"<p><p>Liver cancer is the fourth leading cause of cancer-related death worldwide. In Mexico, there is a high burden of liver cancer mortality in rural states, affecting both women and men equally. Thus, we aimed to describe the demographic and clinical characteristics of hepatocellular cancer (HCC) by sex in Mexico. Demographic and clinical information was extracted retrospectively from the medical records of patients with HCC initially treated (2015-2022) at institutions participating in a national survey across the country. The male-to-female ratio was calculated at the national and regional levels, and the results were stratified by sex. Among 697 HCC patients, the age at diagnosis was 65.4 ± 11.9 years and 20% were diagnosed at ≥75 years. The male-to-female ratio was 1.4:1, ranging from 1:1 in the northwestern and southwestern regions, to 2.1:1 in the western region. The proportion of cirrhosis was similar between the sexes; however, the etiology of cirrhosis differed: cryptogenic cirrhosis was higher in women and alcohol consumption was higher in men. Men had a higher proportion of advanced HCC, poor/undifferentiated tumors, and ≥4 nodules than women. HCC in the Mexican population affects both men and women at a 1.4:1 male-to-female ratio. This unique proportion by sex could be explained by the differences in the prevalence of risk factors across our heterogeneous country.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Significance of Whole-Body Computed Tomography Scans in Pediatric Out-of-Hospital Cardiac Arrest Patients Without Prehospital Return of Spontaneous Circulation. 对院前无自主循环恢复的院外心脏骤停儿科患者进行全身计算机断层扫描的临床意义。
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-20 DOI: 10.3390/diseases12100261
Masanori Ishida, Taro Tanaka, Shinichiro Morichi, Hirotaka Uesugi, Haruka Nakazawa, Shun Watanabe, Motoki Nakai, Gaku Yamanaka, Hiroshi Homma, Kazuhiro Saito

Background. Whole-body computed tomography (WBCT) is commonly employed for primary screening in pediatric patients experiencing out-of-hospital cardiac arrest (OHCA) without prehospital return of spontaneous circulation (ROSC). This study aimed to evaluate the cause of OHCA on WBCT and compare WBCT findings between ROSC and non-ROSC groups in non-traumatic pediatric OHCA cases in an emergency department setting. Methods. A retrospective analysis was conducted on 27 pediatric patients (mean age: 32.4 months; median age: 10 months) who experienced non-traumatic OHCA without prehospital ROSC and were transported to our tertiary care hospital between January 2013 and December 2023. WBCT scans were performed to investigate the cause of OHCA, with recorded findings in the head, chest, abdomen, and subcutaneous tissues. Results. In all cases, the direct causes of OHCA were undetermined, and WBCT identified no fatal findings. Statistical comparisons of CT findings between the ROSC and non-ROSC groups revealed significant differences. The non-ROSC group had a higher incidence of brain swelling, loss of cerebral gray-white matter differentiation, symmetrical lung consolidation/ground-glass opacity, cardiomegaly, hyperdense aortic walls, narrowed aorta, gas in the mediastinum, and hepatomegaly compared to the ROSC group. Conclusions. Although WBCT did not reveal the direct cause of OHCA, several CT findings were significantly more frequent in the non-ROSC group, including brain swelling, loss of cerebral gray-white matter differentiation, symmetrical lung consolidation/ground-glass opacity, cardiomegaly, hyperdense aortic wall, narrowed aorta, gas in the mediastinum, and hepatomegaly. These findings, resembling postmortem changes, may aid in clinical decision making regarding the continuation or cessation of resuscitation efforts in pediatric OHCA cases.

背景。全身计算机断层扫描(WBCT)通常用于院外心脏骤停(OHCA)而院前未恢复自主循环(ROSC)的儿科患者的初筛。本研究旨在通过 WBCT 评估 OHCA 的病因,并比较急诊科非创伤性儿科 OHCA 病例中 ROSC 组和非 ROSC 组的 WBCT 结果。方法我们对 2013 年 1 月至 2023 年 12 月间被送往本院三级医院的 27 名儿童患者(平均年龄:32.4 个月;中位年龄:10 个月)进行了回顾性分析,这些患者均经历了非创伤性 OHCA,且无院前 ROSC。为调查 OHCA 的原因,对患者的头部、胸部、腹部和皮下组织进行了 WBCT 扫描。结果在所有病例中,OHCA 的直接原因均未确定,WBCT 没有发现致命的病变。对 ROSC 组和非 ROSC 组的 CT 结果进行统计比较后发现,两者之间存在显著差异。与 ROSC 组相比,非 ROSC 组出现脑肿胀、大脑灰白质分化消失、对称性肺部合并症/地玻璃不透明、心脏肿大、主动脉壁过密、主动脉狭窄、纵隔内有气体和肝脏肿大的几率更高。结论。虽然 WBCT 并未揭示 OHCA 的直接病因,但非 ROSC 组的几种 CT 发现明显多于 ROSC 组,包括脑肿胀、大脑灰白质分化消失、对称性肺部合并症/磨玻璃不透明、心脏肿大、主动脉壁密度过高、主动脉狭窄、纵隔内有气体和肝脏肿大。这些发现与死后变化相似,可帮助临床决定是否继续或停止对小儿 OHCA 病例的复苏工作。
{"title":"Clinical Significance of Whole-Body Computed Tomography Scans in Pediatric Out-of-Hospital Cardiac Arrest Patients Without Prehospital Return of Spontaneous Circulation.","authors":"Masanori Ishida, Taro Tanaka, Shinichiro Morichi, Hirotaka Uesugi, Haruka Nakazawa, Shun Watanabe, Motoki Nakai, Gaku Yamanaka, Hiroshi Homma, Kazuhiro Saito","doi":"10.3390/diseases12100261","DOIUrl":"https://doi.org/10.3390/diseases12100261","url":null,"abstract":"<p><p><b>Background.</b> Whole-body computed tomography (WBCT) is commonly employed for primary screening in pediatric patients experiencing out-of-hospital cardiac arrest (OHCA) without prehospital return of spontaneous circulation (ROSC). This study aimed to evaluate the cause of OHCA on WBCT and compare WBCT findings between ROSC and non-ROSC groups in non-traumatic pediatric OHCA cases in an emergency department setting. <b>Methods.</b> A retrospective analysis was conducted on 27 pediatric patients (mean age: 32.4 months; median age: 10 months) who experienced non-traumatic OHCA without prehospital ROSC and were transported to our tertiary care hospital between January 2013 and December 2023. WBCT scans were performed to investigate the cause of OHCA, with recorded findings in the head, chest, abdomen, and subcutaneous tissues. <b>Results.</b> In all cases, the direct causes of OHCA were undetermined, and WBCT identified no fatal findings. Statistical comparisons of CT findings between the ROSC and non-ROSC groups revealed significant differences. The non-ROSC group had a higher incidence of brain swelling, loss of cerebral gray-white matter differentiation, symmetrical lung consolidation/ground-glass opacity, cardiomegaly, hyperdense aortic walls, narrowed aorta, gas in the mediastinum, and hepatomegaly compared to the ROSC group. <b>Conclusions.</b> Although WBCT did not reveal the direct cause of OHCA, several CT findings were significantly more frequent in the non-ROSC group, including brain swelling, loss of cerebral gray-white matter differentiation, symmetrical lung consolidation/ground-glass opacity, cardiomegaly, hyperdense aortic wall, narrowed aorta, gas in the mediastinum, and hepatomegaly. These findings, resembling postmortem changes, may aid in clinical decision making regarding the continuation or cessation of resuscitation efforts in pediatric OHCA cases.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment. 炎症性前列腺炎加 IBS-D 亚型及与精浆中免疫调节剂失衡的相关性:新颖的联合治疗。
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-18 DOI: 10.3390/diseases12100260
Roberto Castiglione, Gaetano Bertino, Beatrice Ornella Vicari, Agostino Rizzotto, Giuseppe Sidoti, Placido D'Agati, Michele Salemi, Giulia Malaguarnera, Enzo Vicari

We recently demonstrated the effectiveness of long-term treatment with rifaximin and the probiotic DSF (De Simone formulation) in improving urogenital and gastrointestinal symptoms in patients with both chronic inflammatory prostatitis (IIIa prostatitis) and diarrhea-predominant irritable bowel syndrome (IBS-D), relative to patients with IBS-D alone. Because the low-grade inflammation of the intestine and prostate may be one of the reasons for co-developing both IIIa prostatitis and IBS-D, we designed the present study to once again evaluate the efficacy of combined rifaximin and DSF treatment in patients affected by IIIa prostatitis plus IBS-D, but we also measured seminal plasma pro-inflammatory (IL-6) and anti-inflammatory (IL-10) cytokines before and after treatment. Methods: We consecutively enrolled 124 patients with IIIa prostatitis and IBS-D (diagnosed using the Rome III criteria). Patients were randomized into two groups: group A (n = 64) was treated with rifaximin (seven days per month for three months) followed by DSF, and group B (n = 60) was treated with a placebo. By the end of the intervention, 68.7% and 62.5% of patients from group A reported improved NIH-CPSI (National Institute of Health's Chronic Prostatitis Symptom Index) and IBS-SSS (Irritable Bowel Syndrome Severity Scoring System) scores, respectively, compared to only 3.3% and 5% of the placebo group. Group A patients also had significantly lower mean seminal plasma levels of IL-6 (11.3 vs. 32.4 pg/mL) and significantly higher mean levels of IL-10 (7.9 vs. 4.4 pg/mL) relative to baseline, whereas the levels of IL-6 and IL-10 did not change in the placebo group. Conclusions: The combined treatment with rifaximin and DSF appears to represent the optimal approach for addressing a syndrome such as irritable bowel syndrome (IBS-D plus), which frequently co-occurs with prostatitis (IIIa prostatitis). This approach is particularly beneficial in cases where the symptoms are not always clearly delineated, the etiology is multifactorial, and the diagnosis is multilevel.

最近,我们证实了利福昔明和益生菌DSF(De Simone配方)的长期治疗在改善慢性炎症性前列腺炎(IIIa前列腺炎)和以腹泻为主的肠易激综合征(IBS-D)患者的泌尿生殖系统和胃肠道症状方面的疗效,与单纯的肠易激综合征(IBS-D)患者相比效果更好。由于肠道和前列腺的低度炎症可能是 IIIa 型前列腺炎和肠易激综合征(IBS-D)同时发病的原因之一,因此我们设计了本研究,再次评估利福昔明和 DSF 联合治疗 IIIa 型前列腺炎合并肠易激综合征(IBS-D)患者的疗效,同时还测定了治疗前后精浆促炎细胞因子(IL-6)和抗炎细胞因子(IL-10)。研究方法我们连续招募了 124 名 IIIa 级前列腺炎和 IBS-D 患者(根据罗马 III 标准诊断)。患者被随机分为两组:A 组(64 人)接受利福昔明治疗(每月七天,持续三个月),然后接受 DSF 治疗;B 组(60 人)接受安慰剂治疗。干预结束时,A 组分别有 68.7% 和 62.5% 的患者报告 NIH-CPSI(美国国立卫生研究院慢性前列腺炎症状指数)和 IBS-SSS(肠易激综合征严重程度评分系统)评分有所改善,而安慰剂组分别只有 3.3% 和 5%。与基线相比,A组患者精浆中IL-6的平均水平(11.3 pg/mL对32.4 pg/mL)明显降低,IL-10的平均水平(7.9 pg/mL对4.4 pg/mL)明显升高,而安慰剂组的IL-6和IL-10水平没有变化。结论利福昔明和DSF联合治疗似乎是治疗肠易激综合征(IBS-D plus)等综合征的最佳方法,这种综合征经常与前列腺炎(IIIa型前列腺炎)并发。这种方法尤其适用于症状并不总是很明确、病因是多因素的、诊断是多层次的病例。
{"title":"Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment.","authors":"Roberto Castiglione, Gaetano Bertino, Beatrice Ornella Vicari, Agostino Rizzotto, Giuseppe Sidoti, Placido D'Agati, Michele Salemi, Giulia Malaguarnera, Enzo Vicari","doi":"10.3390/diseases12100260","DOIUrl":"https://doi.org/10.3390/diseases12100260","url":null,"abstract":"<p><p>We recently demonstrated the effectiveness of long-term treatment with rifaximin and the probiotic DSF (De Simone formulation) in improving urogenital and gastrointestinal symptoms in patients with both chronic inflammatory prostatitis (IIIa prostatitis) and diarrhea-predominant irritable bowel syndrome (IBS-D), relative to patients with IBS-D alone. Because the low-grade inflammation of the intestine and prostate may be one of the reasons for co-developing both IIIa prostatitis and IBS-D, we designed the present study to once again evaluate the efficacy of combined rifaximin and DSF treatment in patients affected by IIIa prostatitis plus IBS-D, but we also measured seminal plasma pro-inflammatory (IL-6) and anti-inflammatory (IL-10) cytokines before and after treatment. Methods: We consecutively enrolled 124 patients with IIIa prostatitis and IBS-D (diagnosed using the Rome III criteria). Patients were randomized into two groups: group A (n = 64) was treated with rifaximin (seven days per month for three months) followed by DSF, and group B (n = 60) was treated with a placebo. By the end of the intervention, 68.7% and 62.5% of patients from group A reported improved NIH-CPSI (National Institute of Health's Chronic Prostatitis Symptom Index) and IBS-SSS (Irritable Bowel Syndrome Severity Scoring System) scores, respectively, compared to only 3.3% and 5% of the placebo group. Group A patients also had significantly lower mean seminal plasma levels of IL-6 (11.3 vs. 32.4 pg/mL) and significantly higher mean levels of IL-10 (7.9 vs. 4.4 pg/mL) relative to baseline, whereas the levels of IL-6 and IL-10 did not change in the placebo group. Conclusions: The combined treatment with rifaximin and DSF appears to represent the optimal approach for addressing a syndrome such as irritable bowel syndrome (IBS-D plus), which frequently co-occurs with prostatitis (IIIa prostatitis). This approach is particularly beneficial in cases where the symptoms are not always clearly delineated, the etiology is multifactorial, and the diagnosis is multilevel.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External Carotid Artery Entrapment by the Hyoid Bone Associated with an Atherosclerotic Stenosis of the Internal Carotid Artery. 颈内动脉粥样硬化性狭窄伴有舌骨卡压颈外动脉。
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-18 DOI: 10.3390/diseases12100258
Grigol Keshelava, Zurab Robakidze, Devi Tsiklauri

The mechanical compression of an external carotid artery (ECA) is a rare pathology. The compression of the carotid bifurcation can be positional, induced by anatomical elements, or provoked by volumetric formation in the neck area. In this study, we describe a rare case of an entrapment of the ECA. A 67-year-old man who had two episodes of transient ischemic attack (TIA) demonstrated by loss of consciousness was transferred to our hospital. Ultrasonography and computed tomography revealed the atherosclerotic stenosis (80%) of a right internal carotid artery (ICA) and, at the same time, entrapment of the right ECA by the elongated right greater horn of the hyoid bone (GHHB). A 1 cm section of the GHHB was resected. After clamping of the carotid arteries, longitudinal arteriotomy and endarterectomy surgeries were performed from the right ICA. At the two months follow-up examination, the patient's condition was reported as normal, with no episodes of TIA, dysphagia, or pharyngeal discomfort.

颈外动脉(ECA)的机械性压迫是一种罕见的病理现象。颈动脉分叉处的压迫可能是位置性的,也可能是由解剖因素引起的,或者是颈部的体积形成引起的。在本研究中,我们描述了一例罕见的 ECA 夹层病例。一名 67 岁的男子曾两次发作短暂性脑缺血发作(TIA)并伴有意识丧失,后转入我院。超声波检查和计算机断层扫描显示右侧颈内动脉(ICA)动脉粥样硬化性狭窄(80%),同时右侧 ECA 被拉长的右侧舌骨大角(GHHB)夹住。切除了舌骨大角 1 厘米的部分。夹闭颈动脉后,从右侧 ICA 开始进行纵向动脉切开和动脉内膜切除手术。在两个月的随访检查中,患者的状况正常,没有出现 TIA、吞咽困难或咽部不适。
{"title":"External Carotid Artery Entrapment by the Hyoid Bone Associated with an Atherosclerotic Stenosis of the Internal Carotid Artery.","authors":"Grigol Keshelava, Zurab Robakidze, Devi Tsiklauri","doi":"10.3390/diseases12100258","DOIUrl":"https://doi.org/10.3390/diseases12100258","url":null,"abstract":"<p><p>The mechanical compression of an external carotid artery (ECA) is a rare pathology. The compression of the carotid bifurcation can be positional, induced by anatomical elements, or provoked by volumetric formation in the neck area. In this study, we describe a rare case of an entrapment of the ECA. A 67-year-old man who had two episodes of transient ischemic attack (TIA) demonstrated by loss of consciousness was transferred to our hospital. Ultrasonography and computed tomography revealed the atherosclerotic stenosis (80%) of a right internal carotid artery (ICA) and, at the same time, entrapment of the right ECA by the elongated right greater horn of the hyoid bone (GHHB). A 1 cm section of the GHHB was resected. After clamping of the carotid arteries, longitudinal arteriotomy and endarterectomy surgeries were performed from the right ICA. At the two months follow-up examination, the patient's condition was reported as normal, with no episodes of TIA, dysphagia, or pharyngeal discomfort.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11507092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large Neuroendocrine Neoplasms of the Duodenum: Description of Two Rare Subtypes and Technical Details on Surgical Treatment. 十二指肠大型神经内分泌肿瘤:两种罕见亚型的描述和手术治疗的技术细节。
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-18 DOI: 10.3390/diseases12100259
Giorgio Lucandri, Giulia Fiori, Flaminia Genualdo, Francesco Falbo, Andrea Biancucci, Vito Pende, Paolo Mazzocchi, Massimo Farina, Domenico Campagna, Emanuele Santoro

Background: Duodenal neuroendocrine tumors (NETs) are uncommon, accounting for less than 4% of all gastrointestinal neoplasms. Prognosis is related to tumoral staging and grading, as well as to the specific subtype. In this article, we retrospectively describe the clinical presentation and surgical treatment of two rare large duodenal NETs: a high-grade G3 NET and a Gangliocytic Paraganglioma (GP).

Methods: Both patients presented with moderate-to-high-degree abdominal pain, without jaundice. Main vessel involvement and metastatic spread were excluded with imaging, while preoperative bioptic diagnosis was obtained via percutaneous needle citology and endoscopic ultrasound.

Results: The presence of a sessile large lesion contraindicated any conservative approach in favor of a pancreaticoduodenectomy (PD). The detection of soft pancreatic tissue and a narrowed main pancreatic duct led us to perform a pancreaticogastrostomy to restore proper pancreatic drainage and to minimize the risk of postoperative leakage.

Conclusion: PD may be a favorable choice in these cases; this procedure is challenging, but it results in a safer and more favorable clinical outcome for our patients. Pancreaticogastrostomy may guarantee lower rates of postoperative leak and appears to be preferred in this subset of patients.

背景:十二指肠神经内分泌肿瘤(NET十二指肠神经内分泌肿瘤(NET)并不常见,在所有胃肠道肿瘤中所占比例不到4%。预后与肿瘤分期和分级以及特定亚型有关。在本文中,我们回顾性地描述了两种罕见的十二指肠大面积NET的临床表现和手术治疗:一种是高级别G3 NET,另一种是神经节细胞副神经节瘤(GP):这两名患者均表现为中度至高度腹痛,无黄疸。影像学检查排除了主血管受累和转移扩散的可能,术前通过经皮穿刺针引流术和内镜超声检查进行了生物诊断:结果:无柄大病灶的存在排除了任何保守疗法,而选择了胰十二指肠切除术(PD)。由于发现了软胰腺组织和狭窄的主胰管,我们为其实施了胰胃造口术,以恢复正常的胰腺引流,并将术后渗漏的风险降至最低:结论:胰腺胃造瘘术可能是这些病例的有利选择;该手术具有挑战性,但能为患者带来更安全、更有利的临床结果。胰胃造口术可确保降低术后渗漏率,似乎是这类患者的首选。
{"title":"Large Neuroendocrine Neoplasms of the Duodenum: Description of Two Rare Subtypes and Technical Details on Surgical Treatment.","authors":"Giorgio Lucandri, Giulia Fiori, Flaminia Genualdo, Francesco Falbo, Andrea Biancucci, Vito Pende, Paolo Mazzocchi, Massimo Farina, Domenico Campagna, Emanuele Santoro","doi":"10.3390/diseases12100259","DOIUrl":"https://doi.org/10.3390/diseases12100259","url":null,"abstract":"<p><strong>Background: </strong>Duodenal neuroendocrine tumors (NETs) are uncommon, accounting for less than 4% of all gastrointestinal neoplasms. Prognosis is related to tumoral staging and grading, as well as to the specific subtype. In this article, we retrospectively describe the clinical presentation and surgical treatment of two rare large duodenal NETs: a high-grade G3 NET and a Gangliocytic Paraganglioma (GP).</p><p><strong>Methods: </strong>Both patients presented with moderate-to-high-degree abdominal pain, without jaundice. Main vessel involvement and metastatic spread were excluded with imaging, while preoperative bioptic diagnosis was obtained via percutaneous needle citology and endoscopic ultrasound.</p><p><strong>Results: </strong>The presence of a sessile large lesion contraindicated any conservative approach in favor of a pancreaticoduodenectomy (PD). The detection of soft pancreatic tissue and a narrowed main pancreatic duct led us to perform a pancreaticogastrostomy to restore proper pancreatic drainage and to minimize the risk of postoperative leakage.</p><p><strong>Conclusion: </strong>PD may be a favorable choice in these cases; this procedure is challenging, but it results in a safer and more favorable clinical outcome for our patients. Pancreaticogastrostomy may guarantee lower rates of postoperative leak and appears to be preferred in this subset of patients.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Insights from the Western Australian Context. 局部晚期直肠癌的全面新辅助治疗:来自西澳大利亚州的启示
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-17 DOI: 10.3390/diseases12100257
Oliver Oey, Chak Pan Lin, Muhammad Adnan Khattak, Thomas Ferguson, Mary Theophilus, Siaw Sze Tiong, Sayed Ali, Yasir Khan

Background: Recent studies have associated total neoadjuvant therapy (TNT) with better treatment adherence, decreased toxicity, improved complete clinical response and anal sphincter preservation rates in patients with locally advanced rectal cancer (LARC). However, real-world experience with TNT in the management of LARC remains limited.

Aim: This study aimed to evaluate the efficacy and safety outcomes of TNT for LARC in Western Australia.

Methods: Patients with LARC (cT2-4 and/or cN1-2) who underwent induction chemotherapy followed by neoadjuvant chemoradiotherapy or neoadjuvant chemoradiotherapy followed by consolidation chemotherapy, followed by surgery were recruited from two hospitals in Western Australia. Efficacy outcomes assessed included clinical response (complete, partial, no response), and pathologic complete response (pCR) rate, R0 resection rate, and R1 resection rate were evaluated. Those patients who achieved clinical complete response following TNT were given the option of active surveillance. The safety and tolerability of TNT were assessed.

Results: 32 patients with LARC were treated with TNT. In total, 17 patients (53%) received chemoradiotherapy followed by consolidation chemotherapy and 15 patients (47%) received induction chemotherapy followed by chemoradiotherapy. Nine (28%) of the patients with LARC treated with TNT had a complete clinical response, twenty-one (66%) patients had a partial clinical response, and two (6%) patients had no response to TNT. Of the 32 patients, 27 (84%) underwent surgery. There was a 100% R0 resection rate. The pCR rate was 15%. pCR, clinical response, and the R0 resection rate were similar between the two TNT regimens. TNT was well tolerated, with the majority of patients (88%) completing the chemotherapy course with grade 1 and 2 adverse effects.

Conclusions: In conclusion, TNT emerges as a promising approach for the management of LARC. However, further research is warranted to refine the optimal TNT protocols, determine its long-term outcomes, and identify patient populations who would benefit the most from this innovative therapeutic strategy.

背景:最近的研究表明,在局部晚期直肠癌(LARC)患者中,全面新辅助治疗(TNT)可提高治疗依从性、降低毒性、改善完全临床反应和肛门括约肌保留率。目的:本研究旨在评估 TNT 在西澳大利亚州治疗 LARC 的疗效和安全性:从西澳大利亚州的两家医院招募了接受诱导化疗后进行新辅助化放疗或接受新辅助化放疗后进行巩固化疗后进行手术的LARC(cT2-4和/或cN1-2)患者。疗效评估包括临床反应(完全反应、部分反应、无反应)、病理完全反应率(pCR)、R0切除率和R1切除率。TNT治疗后获得临床完全应答的患者可选择接受主动监测。对TNT的安全性和耐受性进行了评估:32例LARC患者接受了TNT治疗。共有17名患者(53%)接受了化放疗后的巩固化疗,15名患者(47%)接受了诱导化疗后的化放疗。在接受TNT治疗的LARC患者中,9名患者(28%)获得了完全临床应答,21名患者(66%)获得了部分临床应答,2名患者(6%)对TNT无应答。在32名患者中,27名(84%)接受了手术治疗。R0切除率为100%。两种 TNT 方案的 pCR、临床反应和 R0 切除率相似。TNT耐受性良好,大多数患者(88%)完成了化疗疗程,无1级和2级不良反应:总之,TNT是治疗LARC的一种很有前景的方法。然而,还需要进一步的研究来完善 TNT 的最佳方案,确定其长期疗效,并确定从这一创新治疗策略中获益最多的患者人群。
{"title":"Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Insights from the Western Australian Context.","authors":"Oliver Oey, Chak Pan Lin, Muhammad Adnan Khattak, Thomas Ferguson, Mary Theophilus, Siaw Sze Tiong, Sayed Ali, Yasir Khan","doi":"10.3390/diseases12100257","DOIUrl":"https://doi.org/10.3390/diseases12100257","url":null,"abstract":"<p><strong>Background: </strong>Recent studies have associated total neoadjuvant therapy (TNT) with better treatment adherence, decreased toxicity, improved complete clinical response and anal sphincter preservation rates in patients with locally advanced rectal cancer (LARC). However, real-world experience with TNT in the management of LARC remains limited.</p><p><strong>Aim: </strong>This study aimed to evaluate the efficacy and safety outcomes of TNT for LARC in Western Australia.</p><p><strong>Methods: </strong>Patients with LARC (cT2-4 and/or cN1-2) who underwent induction chemotherapy followed by neoadjuvant chemoradiotherapy or neoadjuvant chemoradiotherapy followed by consolidation chemotherapy, followed by surgery were recruited from two hospitals in Western Australia. Efficacy outcomes assessed included clinical response (complete, partial, no response), and pathologic complete response (pCR) rate, R0 resection rate, and R1 resection rate were evaluated. Those patients who achieved clinical complete response following TNT were given the option of active surveillance. The safety and tolerability of TNT were assessed.</p><p><strong>Results: </strong>32 patients with LARC were treated with TNT. In total, 17 patients (53%) received chemoradiotherapy followed by consolidation chemotherapy and 15 patients (47%) received induction chemotherapy followed by chemoradiotherapy. Nine (28%) of the patients with LARC treated with TNT had a complete clinical response, twenty-one (66%) patients had a partial clinical response, and two (6%) patients had no response to TNT. Of the 32 patients, 27 (84%) underwent surgery. There was a 100% R0 resection rate. The pCR rate was 15%. pCR, clinical response, and the R0 resection rate were similar between the two TNT regimens. TNT was well tolerated, with the majority of patients (88%) completing the chemotherapy course with grade 1 and 2 adverse effects.</p><p><strong>Conclusions: </strong>In conclusion, TNT emerges as a promising approach for the management of LARC. However, further research is warranted to refine the optimal TNT protocols, determine its long-term outcomes, and identify patient populations who would benefit the most from this innovative therapeutic strategy.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11507632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Analysis of the Use of Topical Ocular Anti-Infectives in Galicia (Spain) between 2020 and 2023. 2020 至 2023 年加利西亚(西班牙)局部眼用抗感染药使用情况分析。
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-17 DOI: 10.3390/diseases12100256
Severo Vázquez-Prieto, Antonio Vaamonde, Esperanza Paniagua

Eye infections are a global health and economic problem that affect people of both sexes at any age. Topical application of anti-infectives is widely used in the treatment of these types of infections. However, little is known about the current status and trends of the use of topical ocular anti-infectives in Spain. In the present work, we evaluated the use of this type of drug in the Spanish autonomous community of Galicia and described the variability in its consumption between Galician provinces between 2020 and 2023. In addition, the possible existence of a deviation in consumption at a seasonal level was evaluated, as well as possible changes during the study period. A descriptive, cross-sectional and retrospective study of the use of drugs belonging to the subgroups S01A (anti-infectives) and S01C (anti-inflammatory agents and anti-infectives in combination) of the Anatomic Therapeutic Chemical Classification was carried out. This work demonstrated that the most used topical ocular anti-infective in Galicia was tobramycin and that the use of these types of drugs in our region varied according to the provinces. This study also revealed that the consumption of these medications has remained stable during the period 2020-2023, with no significant seasonal differences observed.

眼部感染是一个全球性的健康和经济问题,影响着任何年龄段的男女老少。局部使用抗感染药物被广泛用于治疗此类感染。然而,人们对西班牙眼部局部抗感染药物的使用现状和趋势知之甚少。在本研究中,我们评估了此类药物在西班牙加利西亚自治区的使用情况,并描述了 2020 年至 2023 年期间加利西亚各省之间的用药差异。此外,我们还评估了可能存在的季节性消费偏差,以及研究期间可能发生的变化。对属于《解剖治疗化学分类》S01A(抗感染药)和 S01C(消炎药和抗感染药复方制剂)亚组的药物使用情况进行了描述性、横断面和回顾性研究。这项研究表明,加利西亚地区使用最多的眼部外用抗感染药是妥布霉素,而这类药物在本地区各省的使用情况各不相同。这项研究还表明,在 2020-2023 年期间,这些药物的消费量保持稳定,没有观察到明显的季节性差异。
{"title":"An Analysis of the Use of Topical Ocular Anti-Infectives in Galicia (Spain) between 2020 and 2023.","authors":"Severo Vázquez-Prieto, Antonio Vaamonde, Esperanza Paniagua","doi":"10.3390/diseases12100256","DOIUrl":"https://doi.org/10.3390/diseases12100256","url":null,"abstract":"<p><p>Eye infections are a global health and economic problem that affect people of both sexes at any age. Topical application of anti-infectives is widely used in the treatment of these types of infections. However, little is known about the current status and trends of the use of topical ocular anti-infectives in Spain. In the present work, we evaluated the use of this type of drug in the Spanish autonomous community of Galicia and described the variability in its consumption between Galician provinces between 2020 and 2023. In addition, the possible existence of a deviation in consumption at a seasonal level was evaluated, as well as possible changes during the study period. A descriptive, cross-sectional and retrospective study of the use of drugs belonging to the subgroups S01A (anti-infectives) and S01C (anti-inflammatory agents and anti-infectives in combination) of the Anatomic Therapeutic Chemical Classification was carried out. This work demonstrated that the most used topical ocular anti-infective in Galicia was tobramycin and that the use of these types of drugs in our region varied according to the provinces. This study also revealed that the consumption of these medications has remained stable during the period 2020-2023, with no significant seasonal differences observed.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11507465/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Evaluating Perfusion with Infrared Fluorescent Angiography on Flap Survival in Head and Neck Free Flap Reconstruction. 用红外荧光血管造影术评估血流灌注对头颈部游离皮瓣重建术中皮瓣存活率的影响
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-16 DOI: 10.3390/diseases12100255
Ayten Saracoglu, Gamze Tanirgan Cabakli, Kemal Tolga Saracoglu, Gul Cakmak, Ilhan Erdem, Tumay Umuroglu, Bulent Sacak, Pawel Ratajczyk

Introduction: Intraoperative fluid management is one of the most important factors affecting optimal perfusion in the microcirculatory area in patients that undergo flap surgery. While insufficient fluid administration in the intraoperative period leads to flap complications and organ dysfunction, volume load can cause complications such as edema in the denervated flap tissue, the opening of the sutures, or fat necrosis. The Infrared Fluorescent Angiography Perfusion Evaluation Device (SPY) is one of the many noninvasive techniques that evaluate the well-being of microcirculation at the tissue level. This device monitors and scores the perfusion distribution in the flap area. This retrospective study aimed to investigate the effect of fluid resuscitation in head and neck free flap transfer surgery on flap quality and patient outcomes according to the change in SPY scores.

Material and method: This study included 39 ASA I-II patients who were aged 18-60 years and underwent simultaneous free flap reconstruction of the head and neck between 2015 and 2021. Patients' blood pressure, body temperature, hemoglobin, pH, and lactate values were recorded at both baseline and end of the operation. Also, the SPY "Infrared Fluorescent Angiography Perfusion Evaluation Device" scores, the amount of intraoperative fluid and transfusion, bleeding and urine output, and the duration of mechanical ventilation, anesthesia and surgery, and the duration and amount of drainage, the length of stay in hospital and intensive care unit, and the presence of flap infection, detachment, necrosis and loss, and re-exploration rate were recorded for the patients.

Results: The difference between the first and last measured SPY values was observed to be positively correlated with the length of stay in the hospital and intensive care unit and the duration of drainage. There was a positive correlation between the length of stay in the hospital and intensive care unit and the duration of drainage, the amount of drainage, as well as the duration of anesthesia and the duration of surgery (p < 0.001). A positive correlation was found between the amount of drainage and the amount of crystalloid solution administered (r = 0.36, p < 0.05). In patients with flap infection, the difference between SPYfirst and SPYlast, the duration of anesthesia, and the duration of surgery were significantly higher. The amount of crystalloid solution given and bleeding and the duration of anesthesia and surgery were found to be significantly higher in mechanically ventilated patients (p < 0.05).

Conclusions: It has been concluded that SPY-guided fluid management can be beneficial in preventing morbidities, such as extended hospital and intensive care stay, by reducing flap infection, mechanical ventilation duration, and drainage, with early diagnosis of insufficient perfusion.

简介术中液体管理是影响皮瓣手术患者微循环区域最佳灌注的最重要因素之一。术中输液不足会导致皮瓣并发症和器官功能障碍,而输液量过多则会引起脱神经皮瓣组织水肿、缝合线张开或脂肪坏死等并发症。红外荧光血管造影灌注评估装置(SPY)是评估组织水平微循环状况的众多无创技术之一。该设备可对皮瓣区域的灌注分布进行监测和评分。这项回顾性研究旨在根据 SPY 评分的变化,探讨头颈部游离皮瓣转移手术中液体复苏对皮瓣质量和患者预后的影响:该研究纳入了39例ASA I-II级患者,他们的年龄在18-60岁之间,在2015年至2021年间接受了头颈部同期游离皮瓣重建术。在基线和手术结束时记录患者的血压、体温、血红蛋白、pH 值和乳酸值。此外,还记录了患者的SPY "红外荧光血管造影灌注评价装置 "评分,术中输液量、输血量、出血量、尿量,机械通气时间、麻醉时间、手术时间,引流时间、引流量,住院时间、重症监护室住院时间,有无皮瓣感染、脱落、坏死、脱落,再植率等:观察发现,首次和最后一次测量的 SPY 值之间的差异与住院时间、重症监护室和引流时间呈正相关。在医院和重症监护室的住院时间与引流时间、引流量、麻醉时间和手术时间呈正相关(p < 0.001)。引流量与晶体液用量呈正相关(r = 0.36,p < 0.05)。在皮瓣感染的患者中,SPYfirst 和 SPYlast 的差异、麻醉时间和手术时间都明显较长。研究发现,机械通气患者的晶体液用量、出血量、麻醉时间和手术时间明显更长(P < 0.05):结论:SPY 指导下的输液管理可以减少皮瓣感染、机械通气时间和引流,早期诊断血流灌注不足,从而有效预防发病,如延长住院时间和重症监护时间。
{"title":"The Effect of Evaluating Perfusion with Infrared Fluorescent Angiography on Flap Survival in Head and Neck Free Flap Reconstruction.","authors":"Ayten Saracoglu, Gamze Tanirgan Cabakli, Kemal Tolga Saracoglu, Gul Cakmak, Ilhan Erdem, Tumay Umuroglu, Bulent Sacak, Pawel Ratajczyk","doi":"10.3390/diseases12100255","DOIUrl":"https://doi.org/10.3390/diseases12100255","url":null,"abstract":"<p><strong>Introduction: </strong>Intraoperative fluid management is one of the most important factors affecting optimal perfusion in the microcirculatory area in patients that undergo flap surgery. While insufficient fluid administration in the intraoperative period leads to flap complications and organ dysfunction, volume load can cause complications such as edema in the denervated flap tissue, the opening of the sutures, or fat necrosis. The Infrared Fluorescent Angiography Perfusion Evaluation Device (SPY) is one of the many noninvasive techniques that evaluate the well-being of microcirculation at the tissue level. This device monitors and scores the perfusion distribution in the flap area. This retrospective study aimed to investigate the effect of fluid resuscitation in head and neck free flap transfer surgery on flap quality and patient outcomes according to the change in SPY scores.</p><p><strong>Material and method: </strong>This study included 39 ASA I-II patients who were aged 18-60 years and underwent simultaneous free flap reconstruction of the head and neck between 2015 and 2021. Patients' blood pressure, body temperature, hemoglobin, pH, and lactate values were recorded at both baseline and end of the operation. Also, the SPY \"Infrared Fluorescent Angiography Perfusion Evaluation Device\" scores, the amount of intraoperative fluid and transfusion, bleeding and urine output, and the duration of mechanical ventilation, anesthesia and surgery, and the duration and amount of drainage, the length of stay in hospital and intensive care unit, and the presence of flap infection, detachment, necrosis and loss, and re-exploration rate were recorded for the patients.</p><p><strong>Results: </strong>The difference between the first and last measured SPY values was observed to be positively correlated with the length of stay in the hospital and intensive care unit and the duration of drainage. There was a positive correlation between the length of stay in the hospital and intensive care unit and the duration of drainage, the amount of drainage, as well as the duration of anesthesia and the duration of surgery (<i>p</i> < 0.001). A positive correlation was found between the amount of drainage and the amount of crystalloid solution administered (r = 0.36, <i>p</i> < 0.05). In patients with flap infection, the difference between SPYfirst and SPYlast, the duration of anesthesia, and the duration of surgery were significantly higher. The amount of crystalloid solution given and bleeding and the duration of anesthesia and surgery were found to be significantly higher in mechanically ventilated patients (<i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>It has been concluded that SPY-guided fluid management can be beneficial in preventing morbidities, such as extended hospital and intensive care stay, by reducing flap infection, mechanical ventilation duration, and drainage, with early diagnosis of insufficient perfusion.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11507313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pneumonia-Related Hospitalizations among the Elderly: A Retrospective Study in Northeast Italy. 老年人因肺炎住院的情况:意大利东北部的一项回顾性研究。
IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-15 DOI: 10.3390/diseases12100254
Silvia Cocchio, Claudia Cozzolino, Patrizia Furlan, Andrea Cozza, Michele Tonon, Francesca Russo, Mario Saia, Vincenzo Baldo

Background: In both the elderly and children, pneumonia remains one of the leading causes of hospitalization. This study aimed to assess the impact of pneumonia-related hospitalizations in the population over 65 years of age in the Veneto Region. Methods: This retrospective study analyzed hospital discharge records for patients aged 65 and older who resided in the Veneto Region and had a diagnosis of pneumonia from 2007 to 2023. The hospitalizations were identified using specific ICD-9-CM codes for pneumonia as a discharge diagnosis. Hospitalization rates, mortality rates, the prevalence of complications and comorbidities, the length of stay, and associated costs were calculated by age and year. Results: From 2007 to 2023, there were 139,201 hospitalizations for pneumonia. Emergency admissions accounted for 92.1% of these cases, and only 2.0% had a specific diagnosis of pneumococcal pneumonia. The median length of stay was 10 days, and the median diagnosis-related group (DRG) tariff per hospitalization was EUR 3307. Excluding the pandemic years, the hospitalization rates remained stable at approximately 850 cases per 100,000 inhabitants before 2019. After 2022, the rates started to increase again. Overall, in the investigated period, the results showed a negative trend (average Annual Percentage Change (AAPC) of -1.931, p < 0.0001). However, when only considering the pre-pandemic years, the trend was stable, while a decline was observed starting in 2020 (AAPC of -19.697, p = 0.001). The overall discharge mortality rates ranged from 13% to 19.3% but were significantly higher in those over 85 years of age (20.6% compared with 6.5% and 12.0% in the 65-74 and 75-84 age groups, respectively). Conclusions: This study highlights the substantial burden of pneumonia in individuals over 65 years of age, showing the impacts on public health.

背景:肺炎仍然是老年人和儿童住院治疗的主要原因之一。本研究旨在评估肺炎对威尼托大区 65 岁以上人口住院治疗的影响。研究方法这项回顾性研究分析了 2007 年至 2023 年期间威尼托大区 65 岁及以上、诊断为肺炎的患者的出院记录。这些住院病人的出院诊断中使用了特定的 ICD-9-CM 肺炎代码。按年龄和年份计算住院率、死亡率、并发症和合并症发生率、住院时间和相关费用。结果:从 2007 年到 2023 年,共有 139,201 人因肺炎住院。其中,92.1%的病例为急诊入院,只有2.0%的病例明确诊断为肺炎球菌肺炎。住院时间中位数为 10 天,每次住院的诊断相关组 (DRG) 费用中位数为 3307 欧元。除去大流行年份,住院率在 2019 年前稳定在每 10 万居民约 850 例。2022 年后,住院率开始回升。总体而言,在调查期内,结果显示出负趋势(平均年百分比变化率为-1.931,p < 0.0001)。然而,如果只考虑大流行前的年份,则趋势稳定,但从 2020 年开始出现下降(年平均百分比变化为-19.697,p = 0.001)。总体出院死亡率从 13% 到 19.3% 不等,但 85 岁以上人群的死亡率明显更高(20.6%,而 65-74 岁和 75-84 岁年龄组的死亡率分别为 6.5% 和 12.0%)。结论:这项研究凸显了 65 岁以上老人患肺炎的沉重负担,显示了肺炎对公共卫生的影响。
{"title":"Pneumonia-Related Hospitalizations among the Elderly: A Retrospective Study in Northeast Italy.","authors":"Silvia Cocchio, Claudia Cozzolino, Patrizia Furlan, Andrea Cozza, Michele Tonon, Francesca Russo, Mario Saia, Vincenzo Baldo","doi":"10.3390/diseases12100254","DOIUrl":"https://doi.org/10.3390/diseases12100254","url":null,"abstract":"<p><p><b>Background</b>: In both the elderly and children, pneumonia remains one of the leading causes of hospitalization. This study aimed to assess the impact of pneumonia-related hospitalizations in the population over 65 years of age in the Veneto Region. <b>Methods</b>: This retrospective study analyzed hospital discharge records for patients aged 65 and older who resided in the Veneto Region and had a diagnosis of pneumonia from 2007 to 2023. The hospitalizations were identified using specific ICD-9-CM codes for pneumonia as a discharge diagnosis. Hospitalization rates, mortality rates, the prevalence of complications and comorbidities, the length of stay, and associated costs were calculated by age and year. <b>Results</b>: From 2007 to 2023, there were 139,201 hospitalizations for pneumonia. Emergency admissions accounted for 92.1% of these cases, and only 2.0% had a specific diagnosis of pneumococcal pneumonia. The median length of stay was 10 days, and the median diagnosis-related group (DRG) tariff per hospitalization was EUR 3307. Excluding the pandemic years, the hospitalization rates remained stable at approximately 850 cases per 100,000 inhabitants before 2019. After 2022, the rates started to increase again. Overall, in the investigated period, the results showed a negative trend (average Annual Percentage Change (AAPC) of -1.931, <i>p</i> < 0.0001). However, when only considering the pre-pandemic years, the trend was stable, while a decline was observed starting in 2020 (AAPC of -19.697, <i>p</i> = 0.001). The overall discharge mortality rates ranged from 13% to 19.3% but were significantly higher in those over 85 years of age (20.6% compared with 6.5% and 12.0% in the 65-74 and 75-84 age groups, respectively). <b>Conclusions</b>: This study highlights the substantial burden of pneumonia in individuals over 65 years of age, showing the impacts on public health.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11507115/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diseases (Basel, Switzerland)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1